Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Ivermectin on Outpatient Treatment of Covid-19 Patients
IRCT20210213050344N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ivermectin in coronavirus disease 2019 (COVID-19), sponsored by Shiraz University of Medical Sciences. Started Apr 2021; status: completed.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20210213050344N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210213050344N1.